Mild TBI and Concussion Medications on a Pharmacy Lien: Settlement Value Guide

James Wong — Founder & Pharmacist, LienScripts | March 26, 2026 | 7 min read

Even mild traumatic brain injuries and concussions require multiple medications across drug classes — headache prophylaxis, vestibular agents, sleep aids, and cognitive support. Learn why the medication record proves these cases are not as 'mild' as defense counsel claims.

Mild TBI and Concussion Medications on a Pharmacy Lien

A mild traumatic brain injury (mTBI), commonly called a concussion, is a clinical diagnosis that frequently requires three to six concurrent medications despite its classification as "mild." The medication profile for even a Grade 1 concussion — headache prophylaxis, vestibular suppressants, sleep agents, and sometimes cognitive stimulants — documents the real functional impact of the injury and directly counters the defense narrative that "mild" means "minor."

• Mild TBI accounts for approximately 80% of all traumatic brain injuries, yet up to 30% of mTBI patients develop persistent symptoms requiring months of pharmacological management (CDC, 2023)
• Headache prophylaxis (topiramate, amitriptyline, propranolol) prescribed after concussion documents ongoing post-traumatic headache that has not self-resolved
• Vestibular medications (meclizine, ondansetron) prove the patient has documented balance and dizziness complaints confirmed by a physician
• Sleep disturbance medications initiated after the injury demonstrate a new neurological condition — not a pre-existing sleep disorder
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that maps the concussion medication timeline against symptom resolution milestones for demand packages

The "Mild" Label Is a Medical Classification, Not a Settlement Descriptor

The term "mild" in mild TBI refers to the initial Glasgow Coma Scale score (13-15), the duration of loss of consciousness (under 30 minutes), and post-traumatic amnesia (under 24 hours). It does not describe the functional impact or the duration of symptoms. According to James Wong, PharmD, founder of LienScripts, "Defense counsel consistently exploits the word 'mild' to minimize these cases. The medication record is the antidote — when a patient is on four medications three months after a concussion, the treatment profile tells a different story than the diagnostic label."

[!KEY] The word "mild" in mild TBI describes the initial injury severity classification, not the outcome. A multi-medication treatment protocol lasting three to six months or longer objectively demonstrates that the functional impact was significant, regardless of the diagnostic label.

Post-Traumatic Headache Medications

Post-traumatic headache (PTH) is the most common symptom after concussion, affecting 70-90% of mTBI patients. When headaches persist beyond the acute phase (first two weeks), physicians initiate prophylactic medication — a clinical decision that documents the condition as chronic.

First-line prophylactic agents:

• Amitriptyline — a tricyclic antidepressant used at low doses (10-50 mg nightly) for headache prevention. Its prescription for a post-concussion patient is evidence of chronic daily or near-daily headache requiring preventive rather than reactive treatment.
• Topiramate (Topamax) — an anticonvulsant with FDA-approved indications for migraine prevention (FDA label, NDA 020844). Post-traumatic headache that requires topiramate has been classified as a migraine-equivalent condition by the treating provider.
• Propranolol — a beta-blocker used for headache prophylaxis. The addition of a cardiovascular medication to a head injury protocol signals the treating physician is managing a persistent, physiologically based headache condition.

Acute headache agents:

• Sumatriptan (Imitrex) or other triptans prescribed for breakthrough post-traumatic headaches document that the headache pattern meets migraine criteria.
• Ketorolac — an injectable NSAID sometimes used for severe PTH episodes refractory to oral medications.

[!TIP] When reviewing pharmacy records in concussion cases, look for the transition from as-needed acetaminophen or ibuprofen to scheduled prophylactic agents. That transition point is a documented clinical decision that the headaches are chronic and disabling enough to warrant daily preventive medication.

Vestibular and Balance Medications

Dizziness, vertigo, and balance disturbance after concussion reflect vestibular system disruption. Medications prescribed for these symptoms confirm neurological involvement beyond a simple headache.

• Meclizine — an antihistamine vestibular suppressant. Its prescription documents physician-confirmed dizziness or vertigo after the head injury.
• Ondansetron (Zofran) — prescribed for nausea associated with vestibular dysfunction. Persistent nausea weeks after a concussion is evidence of ongoing vestibular compromise.
• Diazepam (low-dose) — sometimes prescribed short-term for acute vestibular crisis in the first weeks after concussion. Its prescription reflects the severity of vestibular symptoms.

Sleep Disturbance Medications

Sleep disruption affects up to 70% of concussion patients and is recognized as a core symptom of post-concussive syndrome. A 2017 study in the journal Sleep found that sleep disturbance after mTBI was associated with worse cognitive outcomes and prolonged recovery (PMID: 28364473).

• Trazodone — the most commonly prescribed sleep agent after concussion. Low-dose trazodone (25-100 mg) restores sleep architecture without the dependence risk of benzodiazepines.
• Melatonin (prescription-strength) — 3-10 mg formulations prescribed for circadian rhythm disruption after head injury.
• Hydroxyzine — used when anxiety-related insomnia complicates the post-concussion sleep disturbance.

Documentation value: New sleep medication prescriptions initiated after the injury — with no prior sleep medication history — directly refute the defense claim that sleep problems are pre-existing.

Cognitive and Mood Medications

When cognitive symptoms (attention deficits, brain fog, processing speed impairment) persist beyond the acute phase, neurologists may prescribe:

• Methylphenidate — for persistent attention deficits interfering with work or daily function.
• Sertraline or escitalopram — SSRIs for post-concussive depression or anxiety that develops in the weeks to months after injury.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "A concussion patient on an SSRI, a headache prophylactic, a vestibular agent, and a sleep medication is a patient with four documented neurological domains affected by a single injury event. That breadth of treatment eliminates any argument that the concussion was trivial."

[!KEY] The settlement value of a mild TBI case increases substantially when the pharmacy record documents multi-domain symptoms — headache, vestibular, sleep, cognitive, mood — each treated with a separate medication. This is objective pharmacological evidence that cannot be dismissed as symptom exaggeration.

How the Pharmacy Lien Captures the Full Concussion Timeline

Concussion recovery is nonlinear. Patients may improve, relapse during cognitive exertion, and require medication adjustments over three to twelve months. A pharmacy lien through LienScripts captures every fill, dose change, and new medication addition across the entire recovery arc.

Key documentation points in the lien record:

• Initial prescriptions (Days 1-14): Acute pain management, anti-nausea, rest-phase medications
• Prophylactic transition (Weeks 2-6): Switch from as-needed to scheduled medications signals chronic symptom development
• Medication additions (Months 1-3): New drug classes added as additional symptoms emerge or fail to resolve
• Dose adjustments (Months 2-6): Titration of prophylactic agents documents ongoing treatment optimization
• Taper attempts (Months 4-12): Failed taper attempts prove the patient still requires the medication

The LienScripts MERIT (Medication Evaluation & Rationale for Injury Treatment) report presents this timeline as a pharmacist-signed clinical summary, providing attorneys with organized, credible documentation for demand packages and mediation.

Frequently Asked Questions